Kinetics of purified protein derivative (PPD) proliferation reflects underlying suppressor mechanisms revealed by limiting dilution analysis (LDA) in patients with extrapulmonary tuberculosis (TB)

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 293-299

  Lukey, P T ^a,b   Latouf, S E ^a   Ress, S R ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Extrapulmonary tuberculosis; Limiting dilution analysis; Proliferation kinetics; Suppression; V shape LDA

Indexed keywords

PHYTOHEMAGGLUTININ; STREPTODORNASE; STREPTOKINASE; TUBERCULIN;

ARTICLE; BACTERIUM CULTURE; CELL KINETICS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MONOCYTE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0031888637     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00512.x     Document Type: Article

References (33)

1. Gryzbowski S. Tuberculosis. A look at the world situation. Chest 1983; 84:56-61.
2. Sunderam G, McDonald RJ, Maniatis T, Oleske J, Kapola R, Reichman LB. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome. JAMA 1986; 256:362-6.
3. Benatar SR. Tuberculosis in the 1980's with particular reference to South Africa. S Afr Med J 1982; 62:359-64.
4. Collie A. Extrapulmonary tuberculosis. Dept Natl Health Epidemiol Comm 1987; 14:1-21.
5. + T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989; 142:1114-9.
6. Lorgat F, Keraan MM, Ress SR. Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-specific accelerated responses to puritied protein derivative (PPD). Clin Exp Immunol 1992; 90:215-8.
7. Lorgat F, Keraan MM, Lukey PT, Ress SR. Evidence for in vivo generation of cytotoxic T-cells: PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Resp Dis 1992; 145:418-23.
8. Shimokata K, Saka H, Murate T, Hasegawa Y, Hasegawa T. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. Chest 1991; 99:1103-7.
9. + T cells in immunity to tuberculosis infection. Trends Microbiol 1993; 1:77-78.
10. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance To Mycobecterium tuberculois infection. Proc Natl Acad Sci USA 1992; 89:12013-7.
11. + T cells: their activation and effector functions. Curr Opin Immunol 1994; 6:453-7.
12. Fujiwara H, Tsuyuguchi I. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy. Chest 1989; 4:530-2.
13. Lefkovits I, Waldman H. Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. Immunol Today 1984; 5:265-8.
14. Dozmorov IM, Lutsenko GV, Sidorov IA, Miller RA. Analysis of cellular interactions in limiting dilution cultures. J Immunol Methods 1996; 189:183-96.
15. Dozmorov IM, Miller RA. Regulatory interactions between virgin and memory CD4 T lymphocytes. Cell Immunol 1996; 172:141-8.
16. Engelman EG, Benike C, Grumet C, Evan RL. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognise and respond to distinct histocompatibility antigens. J Immunol 1981; 127:2124-9.
17. Sharrock CEM, Kaminski E, Man S. Limiting dilution analysis of human T-cells: a useful clinical tool. Immunol Today 1990; 11:281-6.
18. Fazekas de St Grofh S. The evaluation of limiting dilution assays. J Immunol Methods 1982; 49:R11-R23.
19. Lefkovits I, Waldman H. Limiting dilution analysis of cells in the immune system. Cambridge: Cambridge University Press, 1979.
20. Lukey PT, Latouf SE, Ress SR. Memory lymphocytes from tuberculous effusions: PPD stimulates accelerated activation marker expression and cell cycle progression. Clin Exp Immunol 1996; 104:412-8.
21. Rincon M, Flavell RA. Regulation of the activity of the transcription factors AP-I and NFAT during differentiation of precursor CD4(+) T-cells into effector cells. Biochem Soc Trans 1997; 25:347-54.
22. hi 'memory' phenotype display characteristics of activated cells in G1 stage of cell cycle. Cell Immunol 1992; 141:433-43.
23. Manca F, Rossi G, Valle MT et al. Limited clonal heterogeneity of antigen-specific T cells localising in the pleural space during mycobacterial infection. Infect Immun 1991; 59:503-13.
24. Miller RA. Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell. J Immunol 1984; 132:63-68.
25. Miller RA. Clonal endurance and clonal burst size: novel indices of helper T cell heterogeneity. Eur J Immunol 1984; 14:992-7.
26. Dozmorov IM, Kalinichenko VV, Sidorov IA, Miller RA. Antagonistic interactions among T cell subsets of old mice revealed by limiting dilution analysis. J Immunol 1995; 154:4283-93.
27. Gunther J, Haas W, Von Boehmer H. Suppression of T cell responses through competition for T cell growth factor (interleukin 2). Eur J Immunol 1982; 12:247-9.
28. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Svi 1994; 264:1587-9.
29. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin 10. Ann Rev Immunol 1993; 11:165-90.
30. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage co-stimulatory function. J Immunol 1992; 148:3133-9.
31. + T cell. Immunol Today 1994; 15:107-10.
32. Mehra V, Gong JH, Iyer D, Lin Y, Boylen CT, Bloom BR, Barnes PF. Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis 1996; 174:431-4.
33. Shimokata K. Analysis of cellular immunity against tuberculosis in man with special reference to tuberculous pleurisy and cytokines. Kekkaku 1996; 71:591-6.